Johnson & Johnson raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and quarterly results that beat
(This July 17 story has been corrected to clarify that the CFO did not suggest that pending Stelara insurance contracts would be 'favorable,' in paragraph 4) By Patrick Wingrove and Bhanvi Satija (
Eli Lilly on Tuesday forecast 2024 profit above Wall Street estimates on soaring demand for Zepbound, its recently approved weight-loss drug, and said
USDA launches an internal investigation into the deadly Boar's Head outbreak
Harris zeros in on Black men, Trump focuses on women as both seek to fire up key voting blocs
ASML earnings published early, shares fall
Deadly Israeli airstrike targets hospital complex where thousands were sheltering
Bosnians bury 19 victims of devastating floods
IMF sees Mexico economic growth slowing in 2024, 2025
Apple launches new iPad mini with AI features
Royal arm: Prince William tries his hand at flag football in NFL event with kids in London
Al Roker and his oldest daughter, Courtney, team up on a cookbook that celebrates their family
Wizz Air confirms Airbus deliveries until end of 2025